Q BioMed, Inc logo — Q BioMed acquires, develops and finances innovative and unde...

Q BioMed, Inc

Q BioMed acquires, develops and finances innovative and undervalued biotechnologies

Founded 2015 United States New York, United States 2 employees Post Ipo Equity Total: $48.03M Biopharma, Biotechnology

General Information

Company Name Q BioMed, Inc
Founded Year 2015
Location United States New York, United States +2
Employees 2
Industries Biopharma, Biotechnology
Funding Stage Post Ipo Equity
Social

Get notified when Q BioMed, Inc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Q BioMed, Inc

Q BioMed is a biotech acceleration and commercial stage company with a focus on licensing and acquiring undervalued biomedical assets in the healthcare sector. The company is dedicated to providing these assets the strategic resources, developmental support, and expansion capital needed to ensure they meet their developmental potential, enabling them to provide products to patients in need. Founded in 2013 and headquartered in the United States, Q BioMed recently received a $30.00M post-IPO equity investment on 11 May 2021 from Aedesius Holdings. The company's slogan, "Q BioMed acquires, develops and finances innovative and undervalued biotechnologies," encapsulates its core mission in the biopharma and biotechnology industries. With its recent investment, the company is poised to further its capabilities and contribute significantly to the healthcare sector.

Taxonomy: biotech acceleration, commercial stage company, biomedical assets, healthcare sector, licensing, acquiring, developmental support, expansion capital, oncology, radiopharmaceuticals, pharmaceuticals, orphan drugs

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 1 •••• •••• 11 May 2021
Post-IPO Equity •••••• - 17 Dec 2019
Post-IPO Equity •••••• 1
Investor
24 Sep 2018
Post-IPO Equity •••••• - 01 Feb 2018
Post-IPO Equity •••••• - 02 Aug 2017

View All 6 Funding Rounds

Q BioMed, Inc Alternatives & Competitors

Q BioMed, Inc vs

SM Biomed is a professionally managed generic pharmaceutical company engaged in developing ,manufact...

86 employees
Health Care, Industrial
Q BioMed, Inc vs

Medical textile company, specialising in the design, manufacture and supply of healthcare fabrics an...

3 employees
E-Commerce, Manufacturing
Q BioMed, Inc vs

Creators of the InTray and InPouch Diagnostic tools

16 employees

FAQ About Q BioMed, Inc

Q BioMed acquires, develops and finances innovative and undervalued biotechnologies
Q BioMed, Inc was founded in 2015.
Q BioMed, Inc is headquartered in New York, United States.
Q BioMed, Inc operates in the following industries: Biopharma, Biotechnology.
Q BioMed, Inc has approximately 2 employees.
Q BioMed, Inc has completed 6 funding rounds, raising a total of $48.03M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Q BioMed, Inc include SM Biomed Sdn Bhd, Biomed Technology Australia, Biomed Diagnostics, a DCN Dx Brand., L&K Biomed, Biomed Industries Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Q BioMed, Inc and SM Biomed Sdn Bhd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Q BioMed, Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy